CHOSA ONCOLOGY Aktie

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. On June 2, 2025, the Board of Directors of Chosa Oncology AB ("Chosa" or the "Company”) resolved on a directed issue of shares and warrants series TO 2 of initially approximately SEK 3.4 million (the “Directed Issue”), and on a...

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.  Today, on 13 June 2025, the annual general meeting was held in Chosa Oncology AB. A summary of the adopted resolutions follows below. Resolution on adoption of accounts and distribution of the company's profit The annual general meeting resolved to adopt the profit and loss statement and balance sheet as well as the consolidated profit and loss statement and consolidated balance sheet. The annual general meeting  also...

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Today marks the start of the subscription period in Chosa Oncology AB (publ)'s (“Chosa” or the “Company”) rights issue of shares and warrants amounting to approximately SEK 16.5 million, as resolved by the Board of Directors on 2...

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. June 10, 2025 – Chosa Oncology AB (“Chosa” or the “Company”) has prepared a simplified information document (the “Simplified Information Document”) in connection with the Company's upcoming rights issue of units consisting of...

- to hear how our unique Cisplatin Response Predictor aims to transform the use of cis- and carboplatin in oncology and our capital raise The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. 09 June 2025 CHOSA Oncology invites investors to upcoming presentations on our precision oncology platform We are pleased to invite both current and prospective investors to meet our executive team at two upcoming investor events in June, where we will share the latest developments in our...

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. 2 June 2025 - The Board of Directors of Chosa Oncology AB ("Chosa" or the "Company") has today, based on the authorization granted by the annual general meeting on 31 May 2024, resolved on a directed issue of shares and warrants...

The shareholders of Chosa Oncology AB, Reg. No. 559037-2271, are invited to attend the annual general meeting to be held on Friday 13 June 2025 at 1.00 p.m. at Medicon Village, in the main building the Spark, conference room Collaboraction, Scheeletorget 1, Lund, Sweden. The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.    Right to participate and notification Shareholders wishing to participate in the annual general meeting must: · partly be listed in the company's...

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.   Today, on 23 October 2024, an extraordinary general meeting was held in Chosa Oncology AB. A summary of the adopted resolutions follows below.   Election of new board member as well as remuneration for the new board member The extraordinary general meeting resolved in accordance with the proposal from Buhl Krone Holding ApS (“Buhl Krone”) to elect Fred R. Hirsch as new board member alongside the current board...